Cleared Traditional

K222672 - Disposable Insulin Syringe

K222672 is an FDA 510(k) clearance for Disposable Insulin Syringe, manufactured by Hantech Medical Device Co., Ltd.. The device is a Class 2 General Hospital device with product code FMF cleared through the Traditional 510(k) pathway after a 181-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2023
Decision
181d
Days
Class 2
Risk

K222672 is an FDA 510(k) clearance for the Disposable Insulin Syringe. Classified as Syringe, Piston (product code FMF), Class II - Special Controls.

Submitted by Hantech Medical Device Co., Ltd. (Ningbo, CN). The FDA issued a Cleared decision on March 6, 2023 after a review of 181 days - an extended review cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5860 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General Hospital review framework, consistent with the majority of Class II 510(k) submissions.

View all Hantech Medical Device Co., Ltd. devices

FDA 510(k) Submission Details - K222672

510(k) Number K222672 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 06, 2022
Decision Date March 06, 2023
Days to Decision 181 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
52d slower than avg
Panel avg: 129d · This submission: 181d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

FMF Device Classification - Class 2, Special Controls

Product Code FMF Syringe, Piston
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5860
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FMF Syringe, Piston

All 329
Devices cleared under the same product code (FMF) and FDA review panel - the closest regulatory comparables to K222672.
Sol-Guard Auto-disable Syringe
K220713 · Sol-Millennium Medical, Inc. · May 2023
EpiFinder
K221974 · Omeq Medical , Ltd. · Apr 2023
Sterile Hypodermic Syringe for Single Use
K212207 · Shandong Weigao Group Medical Polymer Co., Ltd. · Mar 2023
Insulin Syringe
K223453 · Promisemed Hangzhou Meditech Co., Ltd. · Mar 2023
CompuFlo Epidural Computer Controlled Anesthesia System
K221702 · Milestone Scientific, Inc. · Feb 2023
Sofjec
K212635 · Hwajin Medical Co., Ltd. · Feb 2023